115 related articles for article (PubMed ID: 19773140)
21. [Surgical palliation for pancreatic cancer. The 25-year experience of a single reference centre].
Popiela T; Kedra B; Sierzega M; Kubisz A
Zentralbl Chir; 2002 Nov; 127(11):965-70. PubMed ID: 12476370
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic cancer: management and survival.
Wakeman CJ; Martin IG; Robertson RW; Dobbs BR; Frizelle FA
ANZ J Surg; 2004 Nov; 74(11):941-4. PubMed ID: 15550079
[TBL] [Abstract][Full Text] [Related]
23. [Digestive cancers in France. Comparison of the incidence in 7 departments and estimation of incidence in the entire country of France].
Launoy G; Grosclaude P; Pienkowski P; Faivre J; Menegoz F; Schaffer P; Schraub S; Pottier D
Gastroenterol Clin Biol; 1992; 16(8-9):633-8. PubMed ID: 1426818
[TBL] [Abstract][Full Text] [Related]
24. [Cancer registry of Calvados, hospital registry of the François- Baclesse Center and mortality statistics: comparisons].
Robillard J; Macé J; Collignon A; Arsène D; Pottier D; Barrellier P; Abbatucci JS
Bull Cancer; 1985; 72(4):298-302. PubMed ID: 4063539
[TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis of 2340 cases of pancreatic cancer].
Zhang QH; Ni QX;
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):214-8. PubMed ID: 15059537
[TBL] [Abstract][Full Text] [Related]
26. Trends in the overall survival of cancer patients diagnosed 1964-2003 in the Nordic countries followed up to the end of 2006: the importance of case-mix.
Storm HH; Kejs AM; Engholm G; Tryggvadóttir L; Klint A; Bray F; Hakulinen T
Acta Oncol; 2010 Jun; 49(5):713-24. PubMed ID: 20491527
[TBL] [Abstract][Full Text] [Related]
27. Multiple myeloma in north east Scotland: a review of incidence and survival over three decades.
Soutar RL; Dawson AA; Wilson BJ
Health Bull (Edinb); 1996 May; 54(3):232-40. PubMed ID: 8707567
[TBL] [Abstract][Full Text] [Related]
28. Interpreting trends of pancreatic cancer incidence and mortality: a nation-wide study in Sweden (1960-2003).
Luo J; Adami HO; Reilly M; Ekbom A; Nordenvall C; Ye W
Cancer Causes Control; 2008 Feb; 19(1):89-96. PubMed ID: 17943451
[TBL] [Abstract][Full Text] [Related]
29. Effect of different treatment methods on survival in patients with pancreatic cancer.
Brasiūniene B; Juozaityte E; Inciūra A; Brasiūnas V; Barauskas G
Rocz Akad Med Bialymst; 2003; 48():66-9. PubMed ID: 14737944
[TBL] [Abstract][Full Text] [Related]
30. Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States.
Lau MK; Davila JA; Shaib YH
Pancreas; 2010 May; 39(4):458-62. PubMed ID: 19924019
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic modalities and treatment of cancer of the pancreas. Evolution in the population in the department of Côte d'Or from 1976 to 1988].
Fauconnier J; Faivre J; Quipourt V; Liabeuf A; Moutet JP; Michiels C
Gastroenterol Clin Biol; 1993; 17(5):341-6. PubMed ID: 8349068
[TBL] [Abstract][Full Text] [Related]
32. Population-based study of islet cell carcinoma.
Yao JC; Eisner MP; Leary C; Dagohoy C; Phan A; Rashid A; Hassan M; Evans DB
Ann Surg Oncol; 2007 Dec; 14(12):3492-500. PubMed ID: 17896148
[TBL] [Abstract][Full Text] [Related]
33. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.
Goh BK; Tan YM; Chung YF; Cheow PC; Ong HS; Chan WH; Chow PK; Soo KC; Wong WK; Ooi LL
Arch Surg; 2008 Oct; 143(10):956-65. PubMed ID: 18936374
[TBL] [Abstract][Full Text] [Related]
34. Incidence and survival of gastric non-Hodgkin's lymphoma: a population-based study from the Association of the French Cancer Registries (FRANCIM).
Danzon A; Belot A; Maynadié M; Remontet L; Dupont AC; Carbonnel F;
Acta Oncol; 2009; 48(7):977-83. PubMed ID: 19551530
[TBL] [Abstract][Full Text] [Related]
35. [Descriptive epidemiology of cancer of the esophagus in the Department of Calvados: 520 cases (1978-1982)].
Chérié-Challine L; Pottier D; Gignoux M
Gastroenterol Clin Biol; 1988 Feb; 12(2):126-32. PubMed ID: 3366315
[TBL] [Abstract][Full Text] [Related]
36. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
[TBL] [Abstract][Full Text] [Related]
37. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
Randén M; Rutqvist LE; Johansson H
Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
[TBL] [Abstract][Full Text] [Related]
38. Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012.
Colonna M; Danzon A; Delafosse P; Mitton N; Bara S; Bouvier AM; Ganry O; Guizard AV; Launoy G; Molinie F; Sauleau EA; Schvartz C; Velten M; Grosclaude P; Tretarre B
Eur J Cancer; 2008 Jan; 44(1):115-22. PubMed ID: 18032021
[TBL] [Abstract][Full Text] [Related]
39. [Cancer of the prostate in France: results of the survey CCAFU-FRANCIM].
Soulié M; Villers A; Grosclaude P; Menegoz F; Schaffer P; Mace-Lesec'h J; Sauvage-Machelard M; Molinier L; Grand A
Prog Urol; 2001 Jun; 11(3):478-85. PubMed ID: 11512461
[TBL] [Abstract][Full Text] [Related]
40. Nationwide improvement of only short-term survival after resection for pancreatic cancer in the Netherlands.
Nienhuijs SW; van den Akker SA; de Vries E; de Hingh IH; Visser O; Lemmens VE
Pancreas; 2012 Oct; 41(7):1063-6. PubMed ID: 22617713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
